BDBM3201 (+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-hydroxybenzoyl]oxy]-4-(4-hydroxybenzyl)pyrrolidine, Trifluoroacetic Acid Salt::2-{[2,6-dihydroxy-4-({[(3S,4R)-4-[(4-hydroxyphenyl)methyl]pyrrolidin-3-yl]oxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Acyclic Balanol Analog 35b

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CNC[C@H]1Cc1ccc(O)cc1

InChI Key InChIKey=MKPSMRQVGPTYRL-UHFFFAOYSA-N

Data  15 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 15 hits for monomerid = 3201   

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 260nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 30nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 40nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 5nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 1.80E+3nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 4.30E+3nMAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 260nMAssay Description:Inhibition of protein kinase C alphaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 20nMAssay Description:Inhibition of protein kinase C etaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 40nMAssay Description:Inhibition of protein kinase C gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 5nMAssay Description:Inhibition of protein kinase C deltaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of protein kinase C epsilonMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 10nMAssay Description:Inhibition of protein kinase C beta IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3201((+-)-anti-3-[[4-(6-Carboxy-2-hydroxybenzoyl)-3,5-h...)
Affinity DataIC50: 30nMAssay Description:Inhibition of protein kinase C beta IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article